# Dexmedetomidine Neuroprotection in Pediatric Cardiac Surgery

> **NCT04484922** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04484922
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-25
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484922, "Dexmedetomidine Neuroprotection in Pediatric Cardiac Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04484922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*